Comparison of Different Gfr Measurements in Chronic Kidney Diseases

Resident Doctor at Clinical Pathology Departement

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05696028

Enrollment

166

Registered

2023-01-25

Start date

2023-02-01

Completion date

2023-12-01

Last updated

2023-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Diseases

Brief summary

Comparison of different Gfr measurements in Chronic Kidney Diseases

Detailed description

Comparison of gfr measured by different method as radionuclide method and creatinine clearance

Interventions

DEVICEGamma counter

DTpA

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

40 Years to 60 Years

Inclusion criteria

* patients with proven or suspected CKD who will be referred to nuclear medicine departement of Assuit University hospital and will undergo dynamic renal imaging.

Exclusion criteria

* Severely ill patients * Disturbed conscious level * Patients on dialysis * patients have oedema or ascites

Design outcomes

Primary

Measure	Time frame	Description
Is to Compare gfr measured by radionuclide method to gfr measured by creatinine clearance in patients with CKD	1year	Gfr can be measured by quantification of plasma and standard volume sample using a quality controlled gamma\_counter and Gamma camera these techniques the central assumption that the tracer is cleared solely by glomerular filtration.

Contacts

Primary ContactAsmaa Zidan, doctor

Zasmaa650@gmail.com01094828826

Backup ContactRanda El Zohne, doctor

randaelzohne@yahoo.com01003390690

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026